Quick Answer
Armata Pharmaceuticals, Inc. reported Stockholders Equity of -$218.60 million for the year ending 2025.
- Armata Pharmaceuticals, Inc. showed a decrease of -355.2% in Stockholders Equity from 2024 to 2025.
- This data is from Armata Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2012: $13.01 million | Q1 2014: -$24.11 million | Q2 2014: -$9.02 million | Q3 2014: $11.34 million | Q1 2015: -$3.08 million | Q2 2015: $13.09 million | Q3 2015: $15.66 million | Q1 2016: $8.90 million | Q2 2016: $21.48 million | Q3 2016: $18.23 million | Q1 2017: $6.65 million | Q2 2017: $9.86 million | Q3 2017: $9.76 million | Q1 2018: $14.71 million | Q2 2018: $11.56 million | Q3 2018: $8.80 million | Q1 2019: $3.96 million | Q2 2019: $22.63 million | Q3 2019: $18.13 million | Q1 2020: $33.48 million | Q2 2020: $29.64 million | Q3 2020: $24.62 million | Q1 2021: $34.01 million | Q2 2021: $28.62 million | Q3 2021: $23.76 million | Q1 2022: $61.54 million | Q2 2022: $53.29 million | Q3 2022: $45.58 million | Q1 2023: $22.45 million | Q2 2023: $19.14 million | Q3 2023: -$12.39 million | Q1 2024: -$56.51 million | Q2 2024: -$46.10 million | Q3 2024: -$50.97 million | Q1 2025: -$53.78 million | Q2 2025: -$69.50 million | Q3 2025: -$95.59 million.
- Over the full 14 years of available data (2012 to 2025), Armata Pharmaceuticals, Inc.'s Stockholders Equity has declined by 1,788.9%.
- Historical annual values: Fiscal year 2025: -$218.60 million | Fiscal year 2024: -$48.02 million | Fiscal year 2023: -$32.07 million | Fiscal year 2022: $36.08 million | Fiscal year 2021: $25.40 million | Fiscal year 2020: $18.86 million | Fiscal year 2019: $14.59 million | Fiscal year 2018: $7.69 million | Fiscal year 2017: $24.34 million | Fiscal year 2016: $9.72 million | Fiscal year 2015: $12.71 million | Fiscal year 2014: $3.44 million | Fiscal year 2013: -$22.63 million | Fiscal year 2012: $12.94 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: